SCHEMBL7303826

SCHEMBL7303826

CCN(CC)CCOc1ccc(Cl)c(C=O)c1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
BIRC5 O15392 1/20 0.43
DRD2 P14416 1/20 0.43
DRD1 P21728 1/20 0.43
DRD3 P35462 1/20 0.43
ALDH1A1 P00352 2/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C19 P33261 2/20 0.38
LTA4H P09960 1/20 0.38
CYP2C9 P11712 1/20 0.38
HTT P42858 1/20 0.38
SIGMAR1 Q99720 2/20 0.38
KDR P35968 1/20 0.38
HRH3 Q9Y5N1 2/20 0.38
PSEN1 P49768 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7313232 0.85 ADRB2 (0.55) KDM4ESMN1; SMN2DRD2DRD1ALDH1A1
SCHEMBL7303821 0.78 KDM4E (0.49) KDM4ESMN1; SMN2BIRC5DRD2DRD1
SCHEMBL9446670 0.74 KDM4E (0.60) KDM4ESMN1; SMN2BIRC5DRD2DRD1
SCHEMBL10806875 0.72 BIRC5 (0.48) KDM4ESMN1; SMN2BIRC5DRD2DRD1
SCHEMBL9827018 0.72 ADRB2 (0.50) KDM4EBIRC5DRD2DRD1DRD3
SCHEMBL327061 0.71 ALDH1A1 (0.45) KDM4EALDH1A1LMNACYP1A2CYP2C19
SCHEMBL7940396 0.71 HPGD (0.57) KDM4ESMN1; SMN2BIRC5ALDH1A1CYP1A2
SCHEMBL2422374 0.71 ALDH1A1 (0.65) KDM4ESMN1; SMN2BIRC5DRD2DRD1
SCHEMBL2524984 0.71 TSHR (0.48) KDM4EALDH1A1KMT2ATDP1CYP3A4
SCHEMBL7310908 0.70 TSHR (0.54) KDM4ESMN1; SMN2DRD2DRD1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5773456-A EMPHYSEMA, RHEUMATOID ARTHRITIS AND PANCREATITIS SANOFI (FR) 1998-06-30 US disclosed
US-5464852-A Used in treatment of degenerative diseases STERLING WINTHROP INC. (US) 1995-11-07 US disclosed
US-5380737-A Enzyme inhibitors STERLING WINTHROP INC. (US) 1995-01-10 US disclosed
EP-0542371-A1 Saccharin derivative proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1993-05-19 EP disclosed